Validation of a New Quantitative Blood Test, Nash-Fibrotest-2 (NT-2), for Assessing Nash Severity in a Phase 2 Clinical Trial of Selonsertib

HEPATOLOGY(2018)

引用 0|浏览20
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要